Replies to post #248732 on NorthWest Biotherapeutics Inc (NWBO)

[sukus]

I need to read Flipper's posts on that. The more I read the more I understand why NWBO seemed to be doing all this which seemed to me to extend this trial per the request of FDA. FDA wanted to make sure the data is mature long enough. 4 year since the last patients enrolled seemed to be the most optimal point.